QLT PhotoTherapeutics (QLTI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QLT PhotoTherapeutics (QLTI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BostonView who wrote (821)	2/11/2000 5:38:00 PM
From: Ian@SI	Read Replies (1) of 1321

I think it's an outstanding buy at this price. And we may get an even better price over the next few days. Briefing.com stated that QLT got an "APPROVAL" Letter from the FDA rather than an "APPROVABLE" letter. This may have caused a premature rise. I doubt it, but it's possible. I just would have expected a stronger gut reaction to QLT not getting an immediate go ahead to start charging real money for treatments provided. Oh well, I guess I'll have to be satisfied with the position that I have as opposed to trying to get some more shares at bargain basement prices. FWIW, Ian. QLT Phototherapeutics Inc. (QLTI) 70 +1/8: Developer of pharmaceutical products for photodynamic therapy receives FDA approval letter for Visudyne therapy to treat the wet form of age-related macular degeneration, a leading cause of blindness in people over the age of 50.....

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next